(2026). IGF2BP3 inhibition: Another home run for RNA-binding protein targeting in hematological malignancies. Haematologica - the Hematology journal.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"IGF2BP3 Inhibition: Another Home Run for RNA-binding Protein Targeting in Hematological Malignancies."
Haematologica - the Hematology Journal 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"IGF2BP3 Inhibition: Another Home Run for RNA-binding Protein Targeting in Hematological Malignancies."
Haematologica - the Hematology Journal, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.